Nordea Investment Management AB Acquires 48,500 Shares of Endo International PLC (NASDAQ:ENDP)

Nordea Investment Management AB grew its holdings in Endo International PLC (NASDAQ:ENDP) (TSE:ENL) by 37.5% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 177,700 shares of the company’s stock after buying an additional 48,500 shares during the period. Nordea Investment Management AB owned 0.08% of Endo International worth $1,427,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. Norges Bank purchased a new position in Endo International in the fourth quarter valued at about $21,218,000. Acadian Asset Management LLC grew its position in shares of Endo International by 83,573.5% in the first quarter. Acadian Asset Management LLC now owns 771,470 shares of the company’s stock valued at $6,194,000 after purchasing an additional 770,548 shares during the last quarter. Canada Pension Plan Investment Board boosted its position in Endo International by 143,723.6% during the fourth quarter. Canada Pension Plan Investment Board now owns 730,624 shares of the company’s stock worth $5,333,000 after acquiring an additional 730,116 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. boosted its position in Endo International by 24.8% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,900,414 shares of the company’s stock worth $15,260,000 after acquiring an additional 378,182 shares during the last quarter. Finally, Diamond Hill Capital Management Inc. boosted its position in Endo International by 18.9% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 1,308,315 shares of the company’s stock worth $9,551,000 after acquiring an additional 208,056 shares during the last quarter. 93.59% of the stock is owned by institutional investors and hedge funds.

Shares of ENDP traded down $0.07 during midday trading on Friday, reaching $3.27. 4,750,934 shares of the stock were exchanged, compared to its average volume of 5,037,137. The stock has a market capitalization of $755.45 million, a P/E ratio of 1.13 and a beta of 1.15. Endo International PLC has a twelve month low of $3.21 and a twelve month high of $18.50. The firm has a 50 day moving average of $4.28.

Endo International (NASDAQ:ENDP) (TSE:ENL) last posted its quarterly earnings results on Thursday, May 9th. The company reported $0.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.42 by $0.11. Endo International had a negative return on equity of 199.18% and a negative net margin of 18.35%. The firm had revenue of $720.00 million for the quarter, compared to analysts’ expectations of $692.31 million. During the same period in the prior year, the business earned $0.67 EPS. The company’s revenue for the quarter was up 2.9% compared to the same quarter last year. As a group, research analysts forecast that Endo International PLC will post 2.17 earnings per share for the current fiscal year.

A number of brokerages have weighed in on ENDP. Gabelli reiterated a “hold” rating on shares of Endo International in a report on Wednesday, March 27th. Mizuho set a $9.00 price target on shares of Endo International and gave the company a “hold” rating in a report on Tuesday, May 14th. Barclays reaffirmed a “hold” rating on shares of Bank of Montreal in a research note on Tuesday, June 11th. Citigroup dropped their price target on shares of Thor Industries from $78.00 to $70.00 in a research note on Monday, June 17th. Finally, Royal Bank of Canada lowered shares of Amneal Pharmaceuticals from an “outperform” rating to a “sector perform” rating and decreased their price objective for the stock from $11.00 to $6.00 in a report on Thursday, July 11th. Four research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and three have assigned a buy rating to the stock. Endo International currently has a consensus rating of “Hold” and a consensus price target of $10.73.

In other Endo International news, Director Roger H. Kimmel sold 34,951 shares of the firm’s stock in a transaction dated Monday, June 17th. The stock was sold at an average price of $3.93, for a total value of $137,357.43. Following the completion of the transaction, the director now owns 148,309 shares in the company, valued at approximately $582,854.37. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.80% of the stock is currently owned by corporate insiders.

About Endo International

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.

See Also: What is a Candlestick Chart?

Institutional Ownership by Quarter for Endo International (NASDAQ:ENDP)

Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.